Evidence map›Paper›PMID 36197088›Full record

ArticlemBio2022

The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.

Khurts Shilagardi, Eric D Spear, Rachy Abraham, Diane E Griffin, Susan Michaelis

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Khurts Shilagardi *Department of Cell Biology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Eric D Spear *Department of Cell Biology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Rachy AbrahamW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Diane E GriffinW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Susan MichaelisDepartment of Cell Biology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins University · US

Funding

The integral membrane protease ZMPSTE24, lamin A processing, and progeriaR01GM041223 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI MICHAELIS, SUSAN D. · 1989 to 2017
$5.0M
The integral membrane protease ZMPSTE24, lamin A processing, and the premature aging disease progeriaR35GM127073 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Susan D. Michaelis · 2018 to 2026
$4.4M
NIGMS NIH HHS R01 GM041223NIGMS NIH HHS R35 GM127073
6 · The paper itself

Abstract

COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a devastating impact on global public health, emphasizing the importance of understanding innate immune mechanisms and cellular restriction factors that cells can harness to fight viral infections. The multimembrane-spanning zinc metalloprotease ZMPSTE24 is one such restriction factor. ZMPSTE24 has a well-characterized proteolytic role in the maturation of prelamin A, precursor of the nuclear scaffold protein lamin A. An apparently unrelated role for ZMPSTE24 in viral defense involves its interaction with the interferon-inducible membrane proteins (IFITMs), which block virus-host cell fusion by rigidifying cellular membranes and thereby prevent viral infection. ZMPSTE24, like the IFITMs, defends cells against a broad spectrum of enveloped viruses. However, its ability to protect against coronaviruses has never been examined. Here, we show that overexpression of ZMPSTE24 reduces the efficiency of cellular infection by SARS-CoV-2 Spike-pseudotyped lentivirus and that genetic knockout or small interfering RNA-mediated knockdown of endogenous ZMPSTE24 enhances infectivity. We further demonstrate a protective role for ZMPSTE24 in a Spike-ACE2-dependent cell-cell fusion assay. In both assays, a catalytic dead version of ZMPSTE24 is equally as protective as the wild-type protein, indicating that ZMPSTE24's proteolytic activity is not required for defense against SARS-CoV-2. Finally, we demonstrate by plaque assays that

Indexed as

COVID-19Murine hepatitis virusAngiotensin-Converting Enzyme 2AnimalsAntiviral AgentsGiant CellsHumansInterferonsLamin Type AMembrane ProteinsMetalloendopeptidasesMetalloproteasesMicePandemicsRNA, Small InterferingSARS-CoV-2Angiotensin-Converting Enzyme 2Antiviral AgentsInterferonsLamin Type AMembrane ProteinsMetalloendopeptidasesMetalloproteasesRNA, Small InterferingSpike Glycoprotein, CoronavirusZincZMPSTE24 protein, humanZmpste24 protein, mousecoronavirusCOVID-19innate immune responseprelamin Aproteasesrestriction factorSARS-CoV-2ZMPSTE24

Identifiers

PMID36197088
PMCPMC9601121
OpenAlexW4302028554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.